The absence of SIRT6 significantly inhibits the activation of prostate cancer-related signaling pathways such as the Notch pathway, thereby inhibiting the proliferation and metastasis of prostate cancer cell lines (123). The gene discussed is SIRT6; the disease is prostate carcinoma.